kpv klow peptide Blend Research Vial KLOW Peptide Blend (RUO) |

Theoretical Risks Cancer risk: By activating the HGF/c-Met pathway, Dihexa could theoretically promote uncontrolled cell growth, raising concerns about tumor development

Lot Traceability and Public COA Library Every vial carries a lot identifier printed on the label that ties to one complete analytical record - HPLC, LC-MS, and endotoxin

Cagrilintide Peptide is listed by National Science Labs as a research-designated laboratory material for structured experimental programs involving peptide or related pathway work

2023;58:125065.e6

In addition, the androgen synthesis inhibitor abiraterone is a treatment for metastatic castration-resistant prostate cancer

Stability: Long shelf-life under proper storage conditions